Open label vancomycin in primary sclerosing cholangitis-inflammatory bowel disease: improved colonic disease activity and associations with changes in host-microbiome-metabolomic signatures
Mohammed Nabil Quraishi*, Jonathan Cheesbrough, Peter Rimmer, Benjamin H Mullish, Naveen Sharma, Elena Efstathiou, Animesh Acharjee, Georgios Gkoutus, Arzoo Patel, Julian R Marchesi, Stephane Camuzeaux, Katie Chappell, Maria A Valdivia-Garcia, James Ferguson, Matthew Brookes, Martine Walmsley, Amanda Rossiter, Willem van Schaik, Ross S McInnes, Rachel CooneyMichael Trauner, Andrew Beggs, Tariq Iqbal, Palak J Trivedi
Research output: Contribution to journal › Article › peer-review
69Downloads
(Pure)
Fingerprint
Dive into the research topics of 'Open label vancomycin in primary sclerosing cholangitis-inflammatory bowel disease: improved colonic disease activity and associations with changes in host-microbiome-metabolomic signatures'. Together they form a unique fingerprint.